CommercialCoverageMedium impact
Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds
Blue Cross & Blue Shield of Mississippi·MS · Urology, Oncology, Radiology·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has updated their medical policy for prostate cancer brachytherapy with permanently implanted seeds. The policy covers permanent brachytherapy as medically necessary for localized prostate cancer when used alone or with external-beam radiotherapy, but considers focal/subtotal prostate brachytherapy investigational.
Action Required
Immediately: Billing team must ensure prostate volume study procedures are coded with CPT 76873. Verify that brachytherapy claims include appropriate risk stratification documentation (PSA levels, Gleason scores, clinical staging) per policy guidelines. Flag any focal or subtotal prostate brachytherapy claims as these may be denied as investigational.